MedTrace Logo

Shared Decision Making With Anal Cancer Patients on Radiation Dose

NCT02785263 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 27

Last updated 2025-07-08

No results posted yet for this study

Summary

The purpose of this study is to maximize patient involvement in the treatment of anal cancer. Specifically, the investigators will investigate whether patients wish to take part in the decision making on radiation dose and whether they want a high or low radiation dose.

Conditions

Interventions

RADIATION

2.15 gray and 1.8 gray. Max. 6 weeks.

RADIATION

2.15 gray and 1.8 gray. Max. 5 weeks.

Sponsors & Collaborators

  • Vejle Hospital

    lead OTHER

Principal Investigators

  • Lars H Jensen, MD,PhD · Vejle Hospital

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-06-30
Primary Completion
2021-06-30
Completion
2025-06-30

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02785263 on ClinicalTrials.gov